Knalysis Technologies is a KIRA Award Finalist!

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 26, 2018 (GLOBE NEWSWIRE) — Knalysis Technologies (“Knalysis”), a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is thrilled to announce that we are one of three finalists for the KIRA Award for the Most

By |2021-08-31T16:27:03+00:00April 26th, 2018|News|

Abba Medix Receives its License to Produce Cannabis Oil

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 23, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that: Its Abba Medix Corp subsidiary has received from Health Canada its License to Produce Cannabis Oil; and It will

By |2021-08-31T16:27:03+00:00April 23rd, 2018|Uncategorized|

Canada House Wellness Group Announces Six-Month Extension to the Term of Warrants Issued on March 13, 2015

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 16, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) announces that it has extended the expiry date in respect of 5,187,723 common share purchase warrants originally issued by the Company as a part

By |2021-08-31T16:27:03+00:00April 10th, 2018|News, News, News, News, News, News|

Canada House Wellness Group Update: Abba Medix Grow is Commencing

TORONTO, March 22, 2018 (GLOBE NEWSWIRE) — Abba Medix Corp “Abba”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) wishes to announce that it received its starting genetics yesterday. With forty-seven strains now in house, the experienced team at Abba will begin cultivation in the coming days. Abba will

By |2021-08-31T16:27:04+00:00April 10th, 2018|Uncategorized|

Early Warning Report Filed Pursuant to National Instrument 62-103

TORONTO, April 02, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”): This press release is being disseminated as required by National Instrument 62-103 The Early Warning System and Related Take Over Bids and Insider Reporting Issues in connection with the acquisition of securities of the Company by Mr. Fabian Henry (“Mr. Henry”

By |2021-08-31T16:27:04+00:00April 10th, 2018|Uncategorized|

Canada House Announces Third Quarter Fiscal 2018 Results

Cash Position Improves to $10.9 million, up from $0.7 million as at April 30, 2017 Shareholders Equity improves to $8.2 million compared to a deficit of $1.2 million as at April 30, 2017 NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 03, 2018 (GLOBE NEWSWIRE) — Canada House

By |2021-08-31T16:27:04+00:00April 10th, 2018|Uncategorized|

Canada House Announces Appointment of Chief Financial Officer

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 09, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) today announced the appointment of Paul Hart as Chief Financial Officer of the Company. The Company is pleased to welcome Mr. Hart as its

By |2021-08-31T16:27:04+00:00April 10th, 2018|Uncategorized|

About

Canada House Wellness Group is a leading cultivator of medical-grade, high-quality cannabis, and provider of cannabinoid therapy, targetting the medical & recreational markets globally.

Canada House (CHV.CN)

Recent Posts

Contact us

Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.
Go to Top